Co-Authors
This is a "connection" page, showing publications co-authored by Jiahong Xia and Ye-Mao Liu.
Connection Strength
0.283
-
A risk score based on baseline risk factors for predicting mortality in COVID-19 patients. Curr Med Res Opin. 2021 06; 37(6):917-927.
Score: 0.059
-
The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19. Cell Metab. 2021 02 02; 33(2):258-269.e3.
Score: 0.058
-
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020 10 06; 32(4):537-547.e3.
Score: 0.056
-
Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality. Hypertension. 2020 08; 76(2):e15-e17.
Score: 0.055
-
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. Circ Res. 2020 06 05; 126(12):1671-1681.
Score: 0.055